Rankings
▼
Calendar
CGEN (Compugen Ltd.) Stock Financials & Earnings | Market Cap Arena
CGEN
Compugen Ltd.
Mkt Cap
$202M
Healthcare
·
Biotechnology
·
🇮🇱 Israel
·
NASDAQ
Revenue (TTM)
$73M
Net Income (TTM)
$35M
EPS (TTM)
$0.37
Free Cash Flow (TTM)
$31M
Gross Margin
87.3%
Op. Margin
43.1%
Net Margin
48.6%
FCF Margin
43.1%
P/S Ratio (TTM)
2.8x
P/E Ratio (TTM)
5.7x
YoY Rev Growth
+161.1%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$10M
Q2 23
$0
$0
-$10M
Q3 23
$0
$0
-$11M
Q4 23
$33M
$31M
$18M
Q1 24
$3M
$457K
-$8M
Q2 24
$7M
$5M
-$3M
Q3 24
$17M
$14M
$4M
Q4 24
$1M
$796K
-$7M
Q1 25
$2M
-$116K
-$8M
Q2 25
$1M
-$408K
-$8M
Q3 25
$2M
$241K
-$8M
Q4 25
$67M
$64M
$56M
marketcaparena.com
Revenue Breakdown
CGEN
Compugen Ltd.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
26.9x
—
Q2 23
26.9x
—
Q3 23
26.9x
—
Q4 23
6.0x
—
Q1 24
5.6x
—
Q2 24
4.7x
—
Q3 24
3.4x
126.4x
Q4 24
7.3x
—
Q1 25
7.3x
—
Q2 25
9.1x
—
Q3 25
29.3x
—
Q4 25
2.8x
5.7x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q3 20
$0
$0
Q4 20
-$17M
-$17M
Q4 21
-$11M
-$11M
Q3 22
$0
$0
Q4 22
-$23M
-$23M
Q1 23
$0
$0
Q2 23
$0
$0
Q3 23
$0
$0
Q1 25
$0
$0
Q2 25
$0
$0
Q3 25
$0
$0
Q4 25
$32M
$31M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q3 20
$0
Q4 20
$40K
Q4 21
$166K
Q3 22
$0
Q4 22
$351K
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q1 25
$0
Q2 25
$0
Q3 25
$0
Q4 25
$306K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+1.4%
Q2 23
—
+6.0%
Q3 23
—
-13.0%
Q4 23
+346.1%
+40.3%
Q1 24
—
+9.0%
Q2 24
—
-1.0%
Q3 24
—
+18.9%
Q4 24
-95.6%
-42.1%
Q1 25
-10.7%
-3.4%
Q2 25
-81.2%
-4.2%
Q3 25
-89.0%
-22.6%
Q4 25
+4477.3%
+26.1%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q3 20
$0
—
Q4 20
$3M
138.6%
Q4 21
$4M
—
Q3 22
$0
—
Q4 22
$4M
57.7%
Q1 23
$0
—
Q2 23
$0
—
Q3 23
$0
—
Q1 25
$0
0.0%
Q2 25
$0
0.0%
Q3 25
$0
0.0%
Q4 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
$7M
$3M
$116K
—
Q2 23
$8M
$2M
$49K
—
Q3 23
$8M
$2M
$18K
—
Q4 23
$11M
$2M
$61K
—
Q1 24
$6M
$2M
$91K
—
Q2 24
$6M
$2M
$157K
—
Q3 24
$6M
$3M
$161K
—
Q4 24
$6M
$2M
$167K
—
Q1 25
$6M
$2M
$139K
—
Q2 25
$6M
$2M
$141K
—
Q3 25
$6M
—
—
$2M
Q4 25
$6M
—
—
$2M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$74M
$0
$74M
Q2 23
$17M
$49M
$66M
Q3 23
$48M
$10M
$58M
Q4 23
$14M
$37M
$51M
Q1 24
$69M
$32M
$101M
Q2 24
$12M
$80M
$92M
Q3 24
$7M
$105M
$113M
Q4 24
$18M
$85M
$103M
Q1 25
$15M
$89M
$104M
Q2 25
$6M
$87M
$94M
Q3 25
$7M
$79M
$86M
Q4 25
$91M
$55M
$146M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
87M
+0.0%
Q2 23
87M
+0.6%
Q3 23
88M
+1.3%
Q4 23
88M
+0.1%
Q1 24
90M
+1.2%
Q2 24
90M
+0.0%
Q3 24
90M
+0.3%
Q4 24
90M
-0.3%
Q1 25
92M
+3.1%
Q2 25
94M
+1.3%
Q3 25
94M
+0.0%
Q4 25
95M
+1.3%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$2M
5
FY 15
$2M
5
FY 16
$142K
5
FY 17
$0
5
FY 18
$509K
35
FY 19
$0
5
FY 20
$400K
5
FY 21
$1M
5
FY 22
$2M
5
FY 23
$7M
5
FY 24
$6M
5
FY 25
$15M
5
marketcaparena.com